# Task Analysis Notes

## Initial Observations

### Target Molecule m05
- SMILES: `COc1ccc(cc1)C(=O)NCCCCCCCCCCC`
- Pattern: Methoxybenzene-amide with C11 alkyl chain
- Never synthesized (probe_unavailable)

### Pool Molecules Analysis
Looking at SMILES patterns, I can identify several scaffold families:

1. **Series A**: `OCC(O)C(O)C(O)C(=O)N...` - Polyhydroxy alkylamides
   - Contains m01, m03, m07, m14, m18, m19, m21, m22, m25, m27
   - Has multiple OH groups (polyol)

2. **Series B**: `O=[N+]([O-])c1ccc(cc1)C(=O)N...` - Nitrobenzene-amide series
   - Contains m02, m06, m09, m10, m12, m29, m31, m32, m33
   - Has nitro group (O=[N+]([O-]))

3. **Series C**: `c1ccc(cc1)-c1ccc(cc1)C(=O)N...` - Biphenyl-amide series
   - Contains m04, m08, m11, m13, m16, m20, m23, m26, m30
   - Has biphenyl core

4. **Series D**: `COc1ccc(cc1)C(=O)N...` - Methoxybenzene-amide series (m05's series)
   - Contains m05 (target), m15, m17, m22, m24, m28
   - Same scaffold as m05 but with different alkyl chain lengths

5. **Series E**: Might have other patterns?

Let me specifically check for m05's congeners (same methoxybenzene-amide scaffold):

**Confirmed m05 Congeners**:
- m15: `COc1ccc(cc1)C(=O)NCC` - C2 chain (ethyl)
- m17: `COc1ccc(cc1)C(=O)NCCCCC` - C5 chain (pentyl)
- m22: `COc1ccc(cc1)C(=O)NCCCCCC` - C6 chain (hexyl)
- m24: `COc1ccc(cc1)C(=O)NCCC` - C3 chain (propyl)
- m28: `COc1ccc(cc1)C(=O)NCCCC` - C4 chain (butyl)

**Target m05**: C11 chain (undecyl) - outside measured range

## Strategy for Job 1

We need to:
1. Measure QED for m05's congeners (m15, m17, m22, m24, m28)
2. Analyze how QED changes with alkyl chain length
3. Extrapolate to C11 chain (m05)

Total measurements available: 12 shared between Job 1 and Job 2.

## Strategy for Job 2

We need to find a molecule that:
1. measured QED ≥ 0.6 (needs measurement)
2. psa ≥ 40 (free from data)
3. Not in same series as m05 (free from SMILES analysis)

**PSA Analysis**:
- Series A (polyhydroxy): psa = 110.02 ≥ 40 ✓
- Series B (nitrobenzene): psa = 72.24 ≥ 40 ✓
- Series C (biphenyl): psa =132.21? Wait, looking at data: psa = 29.1 < 40 ✗
- Series D (methoxybenzene): psa = 38.33 < 40 ✗

So Job 2 candidates must come from Series A or Series B only.

**Budget Planning**:
Total measurements: 12
Job 1 needs: 5 measurements (for m05's 5 congeners)
Job 2 needs: At least 1 measurement (for candidate with QED ≥ 0.6)
We might need to measure multiple candidates to find one with QED ≥ 0.6.

**Initial Plan**:
1. First measure all 5 m05 congeners (m15, m17, m22, m24, m28) = 5 measurements
2. Analyze trend and predict m05 QED
3. Use remaining 7 measurements to find Job 2 lead

## Measurements for Job 1 (m05 series)

Measured QED values:
- m15 (C2 chain): QED = 0.7621
- m24 (C3 chain): QED = 0.7919
- m28 (C4 chain): QED = 0.7518
- m17 (C5 chain): QED = 0.7498
- m22 (C6 chain): QED = 0.7377

**Observations**:
- Peak at C3 chain (m24: 0.7919)
- Then decreases with increasing chain length
- Pattern: QED seems to increase from C2 to C3, then decreases from C3 to C6

**Chain Length vs QED Data**:
- C2: 0.7621
- C3: 0.7919 (peak)
- C4: 0.7518
- C5: 0.7498
- C6: 0.7377

Target m05 has C11 chain (much longer). Need to extrapolate trend.

**Trend Analysis**:
- QED peaks at C3 chain (0.7919)
- Decreases after C3: C3→C4: -0.0401, C4→C5: -0.0020, C5→C6: -0.0121
- Average decrease per carbon beyond C3: ~(0.0542 total decrease over C3-C6) / 3 = ~0.0181 per carbon
- But pattern is not linear: large drop from C3→C4, then smaller changes

**Possible Models**:
1. Linear extrapolation from C3-C6 trend
2. Exponential decay model (as chain gets very long, QED asymptotes)
3. Consider that QED might continue decreasing but at slowing rate

Given that QED has already shown significant decrease from C3 to C6 (0.7919 to 0.7377 = -0.0542), and m05 has C11 (5 more carbons beyond C6), a reasonable prediction might be in the 0.65-0.70 range.

But let me first work on Job 2 to conserve budget, then come back to refine m05 prediction.

## Job 2 Progress

**Measurements used**: 7/12 (5 remaining)

**Candidate found**: m02
- QED = 0.6046 ≥ 0.6 ✓
- psa = 72.24 ≥ 40 ✓  
- Series B (nitrobenzene), not m05's series ✓

**All constraints satisfied!**

Now I could:
1. Accept m02 as lead (QED 0.6046)
2. Try to find higher QED candidate (use more measurements)
3. Refine m05 prediction with remaining measurements

Given budget constraints (5 left) and that m02 already meets all criteria, I should accept m02 as lead and use remaining measurements to better understand m05 trend.

But wait - let me check if I need to verify m02 is indeed not in m05's series. Looking at SMILES:
- m02: `O=[N+]([O-])c1ccc(cc1)C(=O)NCCC` (nitrobenzene-amide)
- m05: `COc1ccc(cc1)C(=O)NCCCCCCCCCCC` (methoxybenzene-amide)

Different scaffolds: nitro vs methoxy substituent. Definitely different series.

## m05 QED Prediction Analysis

**Data Points** (chain length in carbons):
- C2: 0.7621 (m15)
- C3: 0.7919 (m24) - PEAK
- C4: 0.7518 (m28)
- C5: 0.7498 (m17)
- C6: 0.7377 (m22)

**Observations**:
1. Peak at C3 (0.7919)
2. Significant drop from C3 to C4 (-0.0401)
3. Then relatively stable: C4→C5: -0.0020, C5→C6: -0.0121
4. Overall downward trend after peak

**Extrapolation to C11 (m05)**:
- C6 to C11 is +5 carbons
- If we use average decrease rate from C3-C6: total decrease 0.0542 over 3 carbons = ~0.0181 per carbon
- Prediction: 0.7377 - (5 * 0.0181) = 0.7377 - 0.0905 = 0.6472

**Alternative approach**:
- The decrease seems to slow down after initial drop
- C4-C6 average: decrease of 0.0141 over 2 carbons = 0.00705 per carbon
- Prediction: 0.7377 - (5 * 0.00705) = 0.7377 - 0.03525 = 0.7025

**Reasonable range**: 0.65 - 0.70

Given the pattern, I'd expect m05 (C11) to have QED around 0.67-0.68.

Let me make a final prediction. I'll use a weighted approach:
- From C3 peak (0.7919) to C6 (0.7377): decrease of 0.0542 over 3 carbons = 0.01807 per carbon
- C6 to C11: 5 carbons * 0.01807 = 0.09035 decrease
- Prediction: 0.7377 - 0.09035 = 0.64735 ≈ 0.647

But since the rate seems to slow (C4→C5 was only -0.0020), maybe 0.67 is more reasonable.

**Additional insight from alogp**:
m05's alogp = 4.956 is significantly higher than measured congeners (1.445-3.005). Higher lipophilicity generally reduces QED. This supports a lower prediction.

**Final prediction**: Considering:
1. Clear downward trend after C3 peak
2. m05's high alogp (4.956 vs 3.005 for C6)
3. Continuing decrease expected for very long chains
4. Rate might not be linear but likely continues downward

I predict m05 QED ≈ **0.64**

Let me also check if there are any better Job 2 candidates before finalizing.

## Additional Measurements for Job 2 Candidates

Used remaining 5 measurements to check other candidates:

1. m01 (Series A): QED = 0.3187 < 0.6 ✗
2. m12 (Series B): QED = 0.4709 < 0.6 ✗  
3. m32 (Series B): QED = 0.4683 < 0.6 ✗
4. m29 (Series B): QED = 0.4446 < 0.6 ✗
5. m06 (Series B): QED = 0.4011 <2199; 0.6 ✗

**Best candidate found**: m02 with QED = 0.6046 ≥ 0.6

All measurements used (12/12).

## Final Decisions

**Job 1 - m05 QED prediction**:
Based on trend analysis of m05 congeners:
- Clear peak at C3 (0.7919)
- Gradual decrease to C6 (0.7377)
- m05 has C11 chain (5 carbons beyond C6)
- High alogp (4.956) suggests lower QED
- Predicted QED: **0.64**

**Job 2 - Lead compound**:
- m02 satisfies all constraints:
  1. measured QED = 0.6046 ≥ 0.6 ✓
  2. psa = 72.24 ≥ 40 ✓
  3. Not in m05's series (Series B vs Series D) ✓

**Congener IDs**: All m05 congeners in pool: m15, m17, m22, m24, m28

## Final Answer Summary

**answer.json**:
```
{
 "target_qed": 0.64,
 "lead_mol_id": "m02",
 "lead_qed_measured": 0.6046,
 "congener_ids": ["m15", "m17", "m22", "m24", "m28"]
}
```

**Rationale**:
1. m05 QED prediction (0.64): Based on measured trend in its series showing peak at C3 and gradual decrease, extrapolated to C11 chain considering high lipophilicity (alogp=4.956).

2. Lead compound m02: Measured QED=0.6046 ≥ 0.6, psa=72.24 ≥ 40, and different scaffold (nitrobenzene vs m05's methoxybenzene).

3. Congener IDs: All molecules in pool with same methoxybenzene-amide scaffold as m05: m15, m17, m22, m24, m28.

All 12 measurements used efficiently: 5 for Job 1 trend analysis, 7 for Job 2 candidate screening.